SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A), today announced the release of eArray 5.4 online microarray design tool, which enables users to design custom microRNA (miRNA) ...
The enormous potential of miRNAs is driving new technologies for research, diagnostic, and therapeutic applications. miRNAs, a class of small noncoding RNAs of 19–30 nucleotides in length, regulate ...
PALO ALTO, Calif., Jan. 5, 2005 -- Agilent Technologies Inc. (NYSE: A) today announced a breakthrough development that enables the rapid advance of microarray-based comparative genomic studies in ...
MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...
Analyzing gene expression can provide a roadmap for deciphering the role of specific genes or elaborating critical players in functional metabolic pathways. Companies are pursuing solutions to better ...
Agilent Technologies Inc. and Cogenics, a division of Clinical Data, Inc. have announced that Cogenics has been recertified, for the third year, as a Certified Microarray Service Provider for Agilent ...
MicroRNAs (miRNAs) are small, short non-coding RNAs that bind to specific messenger RNAs (mRNAs) and regulate gene expression either by degradation or by translational inhibition of the mRNA. miRNAs ...
MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback